Carbutamide

Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.

Carbutamide

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	A10BB06 (WHO)
Identifiers
IUPAC name 4-amino-N-(butylcarbamoyl)benzenesulfonamide
CAS Number	339-43-5^Y
PubChem CID	9564
ChemSpider	9189^N
UNII	E3K8P4869P
ChEMBL	ChEMBL448570^Y
CompTox Dashboard (EPA)	DTXSID8022741
ECHA InfoCard	100.005.841
Chemical and physical data
Formula	C11H17N3O3S
Molar mass	271.33 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O=S(=O)(c1ccc(N)cc1)NC(=O)NCCCC
InChI InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15)^N Key:VDTNNGKXZGSZIP-UHFFFAOYSA-N^N
^NY (what is this?)  (verify)

It is classified as first-generation.[1]

It was patented in 1953 and approved for medical use in 1956.[2]

References

1. Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Res. Clin. Pract. 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.
2. Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 449. ISBN 9783527607495.